Literature DB >> 34183733

Various myosteatosis selection criteria and their value in the assessment of short- and long-term outcomes following liver transplantation.

Franziska Alexandra Meister1, Jan Bednarsch1, Iakovos Amygdalos1, Joerg Boecker1, Pavel Strnad2, Philipp Bruners3, Sven Arke Lang1, Tom Florian Ulmer1, Lara Heij1,4, Daniel Antonio Morales Santana1, Wen-Jia Liu1, Georg Lurje5, Ulf Peter Neumann1,6, Zoltan Czigany7.   

Abstract

Body composition and myosteatosis affect clinical outcomes in orthotopic liver transplantation (OLT). Here we aimed to compare the value and limitations of various selection criteria to define pre-transplant myosteatosis in the assessment of short- and long-term outcomes following OLT. We retrospectively analyzed the data of 264 consecutive recipients who underwent deceased donor OLT at a German university medical centre. Myosteatosis was evaluated by preoperative computed-tomography-based segmentation. Patients were stratified using muscle radiation attenuation of the whole muscle area (L3Muslce-RA), psoas RA (L3Psoas-RA) and intramuscular adipose tissue content (IMAC) values. L3Muslce-RA, L3Psoas-RA and IMAC performed well without major differences and identified patients at risk for inferior outcomes in the group analysis. Quartile-based analyses, receiver operating characteristic curve and correlation analyses showed a superior association of L3Muslce-RA with perioperative outcomes when compared to L3Psoas-RA and L3IMAC. Long-term outcome did not show any major differences between the used selection criteria. This study confirms the prognostic role of myosteatosis in OLT with a particularly strong value in the perioperative phase. Although, based on our data, L3Muscle-RA might be the most suitable and recommended selection criterion to assess CT-based myosteatosis when compared to L3Psoas-RA and L3IMAC, further studies are warranted to validate these findings.

Entities:  

Year:  2021        PMID: 34183733     DOI: 10.1038/s41598-021-92798-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  33 in total

1.  3D Slicer as an image computing platform for the Quantitative Imaging Network.

Authors:  Andriy Fedorov; Reinhard Beichel; Jayashree Kalpathy-Cramer; Julien Finet; Jean-Christophe Fillion-Robin; Sonia Pujol; Christian Bauer; Dominique Jennings; Fiona Fennessy; Milan Sonka; John Buatti; Stephen Aylward; James V Miller; Steve Pieper; Ron Kikinis
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

2.  The evolution and impact of sarcopenia pre- and post-liver transplantation.

Authors:  Rahima A Bhanji; Naoki Takahashi; Michael R Moynagh; Praveena Narayanan; Mounika Angirekula; Kristin C Mara; Ross A Dierkhising; Kymberly D Watt
Journal:  Aliment Pharmacol Ther       Date:  2019-02-03       Impact factor: 8.171

3.  Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation.

Authors:  Zoltan Czigany; Wiebke Kramp; Jan Bednarsch; Gregory van der Kroft; Joerg Boecker; Pavel Strnad; Markus Zimmermann; Ger Koek; Ulf Peter Neumann; Georg Lurje
Journal:  Am J Transplant       Date:  2019-09-18       Impact factor: 8.086

4.  Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.

Authors:  Aldo J Montano-Loza; Judith Meza-Junco; Vickie E Baracos; Carla M M Prado; Mang Ma; Glenda Meeberg; Crystal Beaumont; Puneeta Tandon; Nina Esfandiari; Michael B Sawyer; Norman Kneteman
Journal:  Liver Transpl       Date:  2014-03-26       Impact factor: 5.799

5.  Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease.

Authors:  Yoichiro Kitajima; Yuichiro Eguchi; Eriko Ishibashi; Shunya Nakashita; Shigehisa Aoki; Shuji Toda; Toshihiko Mizuta; Iwata Ozaki; Naofumi Ono; Takahisa Eguchi; Kohei Arai; Ryuichi Iwakiri; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2009-11-03       Impact factor: 7.527

6.  Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.

Authors:  Aldo J Montano-Loza; Paul Angulo; Judith Meza-Junco; Carla M M Prado; Michael B Sawyer; Crystal Beaumont; Nina Esfandiari; Mang Ma; Vickie E Baracos
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-06-09       Impact factor: 12.910

7.  Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.

Authors:  Maryam Ebadi; Connie W Wang; Jennifer C Lai; Srinivasan Dasarathy; Matthew R Kappus; Michael A Dunn; Elizabeth J Carey; Aldo J Montano-Loza
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-09-29       Impact factor: 12.910

8.  The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation.

Authors:  Zoltan Czigany; Wiebke Kramp; Isabella Lurje; Hannah Miller; Jan Bednarsch; Sven Arke Lang; Tom Florian Ulmer; Philipp Bruners; Pavel Strnad; Christian Trautwein; Martin Wolfgang von Websky; Frank Tacke; Ulf Peter Neumann; Georg Lurje
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-02-01       Impact factor: 12.910

9.  Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Atsushi Kobayashi; Hisaya Shirai; Siyuan Yao; Shintaro Yagi; Naoko Kamo; Hideaki Okajima; Shinji Uemoto
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-02-17       Impact factor: 12.910

10.  Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models.

Authors:  Maxime Nachit; Maxime De Rudder; Jean-Paul Thissen; Olivier Schakman; Caroline Bouzin; Yves Horsmans; Greetje Vande Velde; Isabelle Anne Leclercq
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-11-26       Impact factor: 12.910

View more
  4 in total

1.  Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis.

Authors:  Maryam Ebadi; Cynthia Tsien; Rahima A Bhanji; Abha R Dunichand-Hoedl; Elora Rider; Maryam Motamedrad; Vera C Mazurak; Vickie Baracos; Aldo J Montano-Loza
Journal:  Cells       Date:  2022-04-14       Impact factor: 7.666

2.  The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort.

Authors:  Franziska Alexandra Meister; Georg Lurje; Suekran Verhoeven; Georg Wiltberger; Lara Heij; Wen-Jia Liu; Decan Jiang; Philipp Bruners; Sven Arke Lang; Tom Florian Ulmer; Ulf Peter Neumann; Jan Bednarsch; Zoltan Czigany
Journal:  Cancers (Basel)       Date:  2022-01-30       Impact factor: 6.639

Review 3.  Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions.

Authors:  Maryam Ebadi; Cynthia Tsien; Rahima A Bhanji; Abha R Dunichand-Hoedl; Elora Rider; Maryam Motamedrad; Vera C Mazurak; Vickie Baracos; Aldo J Montano-Loza
Journal:  Cells       Date:  2022-04-04       Impact factor: 6.600

4.  Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosis.

Authors:  Cornelius Engelmann; Niklas F Aehling; Stefan Schob; Ines Nonnenmacher; Luise Handmann; Jane Macnaughtan; Adam Herber; Alexey Surov; Thorsten Kaiser; Timm Denecke; Rajiv Jalan; Daniel Seehofer; Michael Moche; Thomas Berg
Journal:  Hepatol Commun       Date:  2022-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.